Celon Pharma's Generic Semaglutide Reduzek Matches Ozempic, Wegovy in Bioequivalence Study Written By sheeba farhat22 Aug 2026 9:00 PM ISTGdansk: Celon Pharma's experimental semaglutide product Reduzek, a generic alternative to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster...
Aspen's Generic Ozempic Gets Health Canada Approval, Launch Hinges on Dr Reddy's API Supply Written By sheeba farhat21 July 2026 8:44 PM ISTJohannesburg: South Africa's Aspen Pharmacare said on Monday that its Canadian subsidiary had received regulatory approval from Health Canada for...
Sun Pharma Wins SAHPRA Nod to Manufacture, Market Generic Semaglutide Injection in South Africa Written By sheeba farhat15 July 2026 10:02 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited has received approval from the South African Health Products Regulatory Authority (SAHPRA) to...
Recalls by Dr Reddy's, Torrent Put Spotlight on Quality Standards in India's Semaglutide Market Written By Farhat Nasim10 July 2026 5:28 PM ISTNew Delhi: Three Indian pharmaceutical companies, Dr. Reddy's Laboratories, Torrent Pharmaceuticals and USV, have initiated voluntary recalls of...
Brazil Approves First Semaglutide Pen as EMS Challenges Novo Nordisk's Ozempic Written By sheeba farhat27 May 2026 9:53 PM ISTSao Paulo: Brazil's health ​regulator Anvisa said on ​Tuesday it had approved EMS's ​Ozivy, the country's first semaglutide-based injector pen, as the...
Dr Reddy's Labs Among First to Launch Generic Semaglutide in Canada Written By MD Bureau16 May 2026 10:08 PM ISTNew Delhi: Drugmaker Dr. Reddy's Laboratories has announced the launch of its generic Semaglutide Injection in Canada following the receipt of a...
Generic Semaglutide Therapy Cost in India May Drop to Rs 500 a Month: Report Written By Parthika Patel15 May 2026 10:46 PM ISTNew Delhi: Prices of generic semaglutide, the popular weight-loss and anti-diabetes drug, are expected to decline sharply in India over the next six...
Torrent Emerges Early Leader in India's Generic Semaglutide Race with 38% Market Share: Report Written By Susmita Roy9 May 2026 5:23 PM ISTNew Delhi: Ahmedabad-based drug maker Torrent Pharma has emerged as the early frontrunner in India's fast-expanding generic semaglutide market,...
Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge Written By Susmita Roy26 March 2026 11:30 PM ISTNew Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March...
DCGI Orders Audits, Steps Up Action on GLP-1 Weight Loss Drugs Misuse and Marketing Written By Parthika Patel24 March 2026 6:15 PM ISTNew Delhi: In order to ensure ethical pharmaceutical practices in the supply chain of Weight Loss Drug (GLP-1), the Drugs Controller of India has...
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply Written By sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Written By Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
